Mersana Therapeutics Inc (MRSN) — Cash Flow Reinvestment Rate
Mersana Therapeutics Inc (MRSN) has a Cash Flow Reinvestment Rate of 0.30x as of September 2022, reinvesting $16.49 Million (capex $426.00K plus investments $-16.07 Million) from operating cash flow of $54.60 Million. See Mersana Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mersana Therapeutics Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Mersana Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Mersana Therapeutics Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Mersana Therapeutics Inc (2016–2016)
Year-by-year capital reinvestment analysis for Mersana Therapeutics Inc. See Mersana Therapeutics Inc (MRSN) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.07x | $2.17 Million | $31.59 Million | $1.08 Million | — |